- LD 490
-
- $44.00
-
2026-07-15
- CAS:58336-35-9
- Purity:
- Supply Ability: 10g
|
| | 2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin Basic information |
| Product Name: | 2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin | | Synonyms: | 2,3,6,7-tetrahydro-1h,5h,11h-(1)benzopyrano(6,7,8-ij)-quinolizin-11-one;5h,11h-(1)benzopyrano(6,7,8-ij)quinolizin-11-one,2,3,6,7-tetrahydro-1;5h,11h-[1]benzopyrano[6,7,8-ij]quinolizin-11-one,2,3,6,7-tetrahydro-1;2,3,6,7-Tetrahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11(5H)-one;excitonld490;ld490;COUMARIN 540H;COUMARIN 6H | | CAS: | 58336-35-9 | | MF: | C15H15NO2 | | MW: | 241.29 | | EINECS: | 261-213-4 | | Product Categories: | | | Mol File: | 58336-35-9.mol | ![2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin Structure](CAS/GIF/58336-35-9.gif) |
| | 2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin Chemical Properties |
| WGK Germany | 3 | | RTECS | DJ3310000 | | TSCA | TSCA listed | | HS Code | 2934.99.4400 |
| | 2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin Usage And Synthesis |
| Description | LD 490 is a highly-effective biopharmaceutical compound used in the study of leukemia and lymphoma. Acting as a targeted therapy, this medication works by inhibiting specific pathways responsible for cancer cell growth and division. By blocking these pathways, LD 490 effectively slows down tumor progression and improves patient outcomes. |
| | 2,3,5,6-1H,4H-Tetrahydroquinolizino[9,9a,1-gh]coumarin Preparation Products And Raw materials |
|